Zhejiang Zhenyuan Share Co Ltd Asset Resilience Ratio
Zhejiang Zhenyuan Share Co Ltd asset resilience ratio. Zhejiang Zhenyuan Share Co Ltd (000705) has an Asset Resilience Ratio of 5.75% as of March 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Zhejiang Zhenyuan Share Co Ltd (000705) defensive interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Zhejiang Zhenyuan Share Co Ltd (1997–2021)
Asset resilience ratio of Zhejiang Zhenyuan Share Co Ltd from 1997 to 2021. This chart shows how Zhejiang Zhenyuan Share Co Ltd's Asset Resilience Ratio has changed over time. Read Zhejiang Zhenyuan Share Co Ltd debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Zhejiang Zhenyuan Share Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 000705 current and non-current assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥170.00 Million | 5.75% |
| Total Liquid Assets | CN¥170.00 Million | 5.75% |
Asset Resilience Insights
- Limited Liquidity: Zhejiang Zhenyuan Share Co Ltd maintains only 5.75% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Zhejiang Zhenyuan Share Co Ltd Industry Peers by Asset Resilience Ratio
Compare Zhejiang Zhenyuan Share Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Merck & Company Inc
NYSE:MRK |
Drug Manufacturers - General | 0.22% |
|
AstraZeneca PLC
NASDAQ:AZN |
Drug Manufacturers - General | 0.10% |
|
Pfizer Inc
SA:PFIZ34 |
Drug Manufacturers - General | 5.33% |
|
Cosmo Pharmaceuticals N.V
F:C43 |
Drug Manufacturers - General | 10.92% |
|
Zhejiang Int'L Group Co Ltd
SHE:000411 |
Drug Manufacturers - General | 0.00% |
|
Eli Lilly and Company
SA:LILY34 |
Drug Manufacturers - General | 6.46% |
|
Dimed S.A. Distribuidora de Medicamentos
SA:PNVL3 |
Drug Manufacturers - General | 6.34% |
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SHG:600436 |
Drug Manufacturers - General | 17.40% |
Zhejiang Zhenyuan Share Co Ltd Asset Resilience Ratio by Year (1997–2021)
Zhejiang Zhenyuan Share Co Ltd asset resilience ratio by year from 1997 to 2021. The table below shows the annual Asset Resilience Ratio data for Zhejiang Zhenyuan Share Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2021-12-31 | 7.37% | CN¥220.00 Million ≈ $32.19 Million |
CN¥2.99 Billion ≈ $437.00 Million |
+1.81pp |
| 2020-12-31 | 5.55% | CN¥150.00 Million ≈ $21.95 Million |
CN¥2.70 Billion ≈ $395.28 Million |
-4.10pp |
| 2019-12-31 | 9.66% | CN¥250.00 Million ≈ $36.58 Million |
CN¥2.59 Billion ≈ $378.79 Million |
+8.68pp |
| 2015-12-31 | 0.98% | CN¥19.00 Million ≈ $2.78 Million |
CN¥1.94 Billion ≈ $283.62 Million |
-4.60pp |
| 2000-12-31 | 5.58% | CN¥40.00 Million ≈ $5.85 Million |
CN¥716.33 Million ≈ $104.82 Million |
+3.79pp |
| 1999-12-31 | 1.79% | CN¥10.00 Million ≈ $1.46 Million |
CN¥557.35 Million ≈ $81.56 Million |
-5.45pp |
| 1998-12-31 | 7.24% | CN¥40.00 Million ≈ $5.85 Million |
CN¥552.33 Million ≈ $80.82 Million |
+2.24pp |
| 1997-12-31 | 5.00% | CN¥28.00 Million ≈ $4.10 Million |
CN¥559.86 Million ≈ $81.93 Million |
-- |
About Zhejiang Zhenyuan Share Co Ltd
Zhejiang Zhenyuan Share Co.,Ltd. engages in the manufacture and wholesale of pharmaceutical products in China and internationally. Its products include Chinese herbal medicines and slices, Chinese patent medicines, chemical raw materials, chemical preparations, antibiotics, biochemical drugs, biological products, medical devices, chemical reagents, glass instruments, etc. The company also provide… Read more